These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 25438451)

  • 1. New potential biomarkers for disease activity and fibrosis in systemic sclerosis.
    Vadasz Z; Rimar D
    Isr Med Assoc J; 2014 Oct; 16(10):629-30. PubMed ID: 25438451
    [No Abstract]   [Full Text] [Related]  

  • 2. Semaphorin 3A: an immunoregulator in systemic sclerosis.
    Rimar D; Nov Y; Rosner I; Slobodin G; Rozenbaum M; Halasz K; Haj T; Jiries N; Kaly L; Boulman N; Vadasz Z
    Rheumatol Int; 2015 Oct; 35(10):1625-30. PubMed ID: 25895648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Systemic sclerosis--clinical course and treatment possibilities].
    Szymańska E; Maj M; Rudnicka L
    Przegl Lek; 2005; 62(12):1538-41. PubMed ID: 16786791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrosis biomarkers in isolated Raynaud's phenomenon: too little, too soon?
    Ingegnoli F; Gualtierotti R; Schioppo T; Orenti A; Boracchi P; Lubatti C; Mastaglio C; Galbiati V; Murgo A; Zeni S; Grossi C; Borghi O; Rosenberg W; Castelnovo L; Meroni Pier L
    Ann Rheum Dis; 2014 May; 73(5):940-1. PubMed ID: 24344159
    [No Abstract]   [Full Text] [Related]  

  • 5. Circulating endothelin-1 levels in systemic sclerosis subsets--a marker of fibrosis or vascular dysfunction?
    Morelli S; Ferri C
    J Rheumatol; 1996 Apr; 23(4):789-91. PubMed ID: 8730152
    [No Abstract]   [Full Text] [Related]  

  • 6. [Characteristic of the endogenous peptides--endothelins and their role in the connective tissue fibrosis].
    Garncarczyk A; Jurzak M; Gojniczek K
    Wiad Lek; 2008; 61(4-6):126-34. PubMed ID: 18939363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysyl Oxidase in Systemic Sclerosis: Getting Under the Skin.
    Rimar D; Rosner I; Slobodin G; Rozenbaum M; Kaly L; Boulman N; Vadasz Z
    Isr Med Assoc J; 2016 Sep; 18(9):534-536. PubMed ID: 28471599
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hepatic fibrosis in chronic alcoholism].
    Langness U
    Fortschr Med; 1980 Jun; 98(24):920-3, 932. PubMed ID: 6107266
    [No Abstract]   [Full Text] [Related]  

  • 9. Systemic sclerosis refractory disease: from the skin to the heart.
    Almeida I; Faria R; Vita P; Vasconcelos C
    Autoimmun Rev; 2011 Sep; 10(11):693-701. PubMed ID: 21575745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of clonal T cells in the circulation of patients with nephrogenic systemic fibrosis.
    Kreuter A; Höxtermann S; Gambichler T; Tigges C; Hahn SA; Schieren G
    Arch Dermatol; 2009 Oct; 145(10):1164-9. PubMed ID: 19841405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating endothelin-1 levels in systemic sclerosis subsets--a marker of fibrosis or vascular dysfunction?
    Gordon MM; Madhok R
    J Rheumatol; 1996 Apr; 23(4):788-9. PubMed ID: 8730151
    [No Abstract]   [Full Text] [Related]  

  • 12. Activated and resting regulatory T cell exhaustion concurs with high levels of interleukin-22 expression in systemic sclerosis lesions.
    Mathian A; Parizot C; Dorgham K; Trad S; Arnaud L; Larsen M; Miyara M; Hié M; Piette JC; Frances C; Yssel H; Amoura Z; Gorochov G
    Ann Rheum Dis; 2012 Jul; 71(7):1227-34. PubMed ID: 22696687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Histochemical investigations in scleroderma (author's transl)].
    Kreysel HW; Brügge P; Jänner M; Kimmig J
    MMW Munch Med Wochenschr; 1976 Sep; 118(39):1235-40. PubMed ID: 135207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers for skin involvement and fibrotic activity in scleroderma.
    Moinzadeh P; Denton CP; Abraham D; Ong V; Hunzelmann N; Eckes B; Krieg T
    J Eur Acad Dermatol Venereol; 2012 Mar; 26(3):267-76. PubMed ID: 21819452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Systemic sclerosis (scleroderma): etiology and pathogenesis--where are we today?].
    Stoll T; Brühlmann P; Fontana A; Gmür J; Michel BA
    Schweiz Med Wochenschr; 1994 Feb; 124(5):193-203. PubMed ID: 8128201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated serum concentrations of polymorphonuclear neutrophilic leukocyte elastase in systemic sclerosis: association with pulmonary fibrosis.
    Hara T; Ogawa F; Yanaba K; Iwata Y; Muroi E; Komura K; Takenaka M; Shimizu K; Hasegawa M; Fujimoto M; Sato S
    J Rheumatol; 2009 Jan; 36(1):99-105. PubMed ID: 19208531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum CCL13 levels in patients with systemic sclerosis and controls.
    Gambichler T; Yilmaz E; Höxtermann S; Kolios A; Moritz R; Bechara FG; Kreuter A
    Br J Dermatol; 2011 Jul; 165(1):216-8. PubMed ID: 21428976
    [No Abstract]   [Full Text] [Related]  

  • 18. Cartilage oligomeric matrix protein in systemic sclerosis.
    Yamamoto M; Takahashi H; Suzuki C; Naishiro Y; Yamamoto H; Imai K; Shinomura Y
    Rheumatology (Oxford); 2007 Dec; 46(12):1858-9. PubMed ID: 17895282
    [No Abstract]   [Full Text] [Related]  

  • 19. Infectious disease as aetiological factor in the pathogenesis of systemic sclerosis.
    Radić M; Martinović Kaliterna D; Radić J
    Neth J Med; 2010 Nov; 68(11):348-53. PubMed ID: 21158008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of serum clara cell 16-kDa (CC16) levels as a potential indicator of active pulmonary fibrosis in systemic sclerosis.
    Hasegawa M; Fujimoto M; Hamaguchi Y; Matsushita T; Inoue K; Sato S; Takehara K
    J Rheumatol; 2011 May; 38(5):877-84. PubMed ID: 21239758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.